Future Financial Wealth Managment LLC Purchases 925 Shares of UnitedHealth Group Incorporated $UNH

Future Financial Wealth Managment LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 164.9% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,486 shares of the healthcare conglomerate’s stock after acquiring an additional 925 shares during the period. Future Financial Wealth Managment LLC’s holdings in UnitedHealth Group were worth $464,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the business. Citizens National Bank Trust Department boosted its holdings in UnitedHealth Group by 1.0% in the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock valued at $9,368,000 after acquiring an additional 170 shares in the last quarter. Fort Washington Investment Advisors Inc. OH boosted its stake in shares of UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock valued at $277,641,000 after purchasing an additional 1,465 shares in the last quarter. Caitlin John LLC boosted its position in UnitedHealth Group by 14.8% during the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock valued at $451,000 after acquiring an additional 111 shares in the last quarter. Triumph Capital Management bought a new stake in UnitedHealth Group during the 2nd quarter valued at approximately $1,324,000. Finally, Wealth Effects LLC boosted its position in shares of UnitedHealth Group by 14.4% during the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock valued at $1,463,000 after purchasing an additional 591 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Up 1.8%

Shares of UnitedHealth Group stock opened at $360.17 on Friday. The company’s 50 day moving average is $307.84 and its 200 day moving average is $355.58. The company has a market cap of $326.20 billion, a price-to-earnings ratio of 15.61, a price-to-earnings-growth ratio of 2.30 and a beta of 0.47. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the previous year, the company earned $6.80 earnings per share. UnitedHealth Group’s quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is 38.30%.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the stock. Cantor Fitzgerald restated an “overweight” rating and set a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. KeyCorp dropped their price objective on shares of UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 30th. UBS Group reissued a “buy” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Bank of America boosted their price target on UnitedHealth Group from $290.00 to $325.00 and gave the stock a “neutral” rating in a research report on Monday, August 18th. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of UnitedHealth Group in a report on Saturday, September 27th. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.